Clinical Trial Update: Persistence Targeted Smoking Cessation in Serious Mental Illness (SMI) [NA]

View source ↗

Summary

A completed clinical trial on persistence-targeted smoking cessation in individuals with serious mental illness has posted results as of 2022-08-16.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizoaffective Disorder
• Schizophrenia
• Tobacco Use Disorder

Snippet

Sponsor: Rutgers, The State University of New Jersey | Conditions: Tobacco Use, Tobacco Smoking | NA | Status: COMPLETED | Results posted: 2022-08-16